Global University Venturing

Life sciences veteran Gerald J Vardzel has been named president and CEO of University of Pittsburgh’s LifeX Labs.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The brain disease treatment developer was founded in 2019 on the back of more than a decade’s collaborative research from MIT and Harvard.

IP Group subsidiary Parkwalk Advisors is to pour even more funding into the UK's academic deep tech research under a new government tax scheme.

The university marked a 10-year high for spinout generation and revealed its portfolio had cumulatively lured $452m in funding.

IP Group was among the investors for UPenn-founded cancer immunotherapy developer Carisma Therapeutics, which has now raised nearly $109m altogether.

UPMC Enterprise has returned for a $72m series B round raised by Werewolf Therapeutics, which is now set to advance two lead assets through phase 1 trials.

Osage University Partners has contributed to an $80m round for Dice Molecules, which is advancing Stanford University research and is also backed by Sanofi and Alexandria.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

CWRU‘s pain neurostimulation spinout has secured series BB funding ahead of a 180-patient trial.

Biopolymer material decontamination company Karamedica and genomic sequencing provider Murrieta Genomics have both joined UC Riverside's newly-launched Life Sciences Incubator.